​

UDBHR - Contents of Articles

UDBHR - Contents of Articles
28問 • 2023-10-22
  • Via Alarcon
  • 通報

    M6 Vitamins and Co-factors

    M6 Vitamins and Co-factors

    Via Alarcon · 80問 · 3年前

    M6 Vitamins and Co-factors

    M6 Vitamins and Co-factors

    80問 • 3年前
    Via Alarcon

    M7 Enzymes

    M7 Enzymes

    Via Alarcon · 96問 · 3年前

    M7 Enzymes

    M7 Enzymes

    96問 • 3年前
    Via Alarcon

    M8 Metabolic Pathways

    M8 Metabolic Pathways

    Via Alarcon · 104問 · 3年前

    M8 Metabolic Pathways

    M8 Metabolic Pathways

    104問 • 3年前
    Via Alarcon

    GENETICS FINALS

    GENETICS FINALS

    Via Alarcon · 69問 · 3年前

    GENETICS FINALS

    GENETICS FINALS

    69問 • 3年前
    Via Alarcon

    Module 2: Chemical Context of Life

    Module 2: Chemical Context of Life

    Via Alarcon · 15問 · 3年前

    Module 2: Chemical Context of Life

    Module 2: Chemical Context of Life

    15問 • 3年前
    Via Alarcon

    Module 3: Biological Macromolecules

    Module 3: Biological Macromolecules

    Via Alarcon · 22問 · 3年前

    Module 3: Biological Macromolecules

    Module 3: Biological Macromolecules

    22問 • 3年前
    Via Alarcon

    UDBHR - Article and Principle

    UDBHR - Article and Principle

    Via Alarcon · 32問 · 3年前

    UDBHR - Article and Principle

    UDBHR - Article and Principle

    32問 • 3年前
    Via Alarcon

    Cell and Molecular Biology - Module 5-7 (1)

    Cell and Molecular Biology - Module 5-7 (1)

    Via Alarcon · 100問 · 3年前

    Cell and Molecular Biology - Module 5-7 (1)

    Cell and Molecular Biology - Module 5-7 (1)

    100問 • 3年前
    Via Alarcon

    Cell and Molecular Biology - Module 5-7 (2)

    Cell and Molecular Biology - Module 5-7 (2)

    Via Alarcon · 15問 · 3年前

    Cell and Molecular Biology - Module 5-7 (2)

    Cell and Molecular Biology - Module 5-7 (2)

    15問 • 3年前
    Via Alarcon

    UDBHR - The History

    UDBHR - The History

    Via Alarcon · 32問 · 3年前

    UDBHR - The History

    UDBHR - The History

    32問 • 3年前
    Via Alarcon

    General Physiology - MIDTERMS (4)

    General Physiology - MIDTERMS (4)

    Via Alarcon · 34問 · 3年前

    General Physiology - MIDTERMS (4)

    General Physiology - MIDTERMS (4)

    34問 • 3年前
    Via Alarcon

    Laboratory - MIDTERMS

    Laboratory - MIDTERMS

    Via Alarcon · 30問 · 3年前

    Laboratory - MIDTERMS

    Laboratory - MIDTERMS

    30問 • 3年前
    Via Alarcon

    FILDIS - MIDTERMS

    FILDIS - MIDTERMS

    Via Alarcon · 84問 · 2年前

    FILDIS - MIDTERMS

    FILDIS - MIDTERMS

    84問 • 2年前
    Via Alarcon

    PAGSASALIN

    PAGSASALIN

    Via Alarcon · 19問 · 2年前

    PAGSASALIN

    PAGSASALIN

    19問 • 2年前
    Via Alarcon

    Utilitarianism

    Utilitarianism

    Via Alarcon · 32問 · 2年前

    Utilitarianism

    Utilitarianism

    32問 • 2年前
    Via Alarcon

    Moral Theory

    Moral Theory

    Via Alarcon · 26問 · 2年前

    Moral Theory

    Moral Theory

    26問 • 2年前
    Via Alarcon

    Kantian Ethics

    Kantian Ethics

    Via Alarcon · 20問 · 2年前

    Kantian Ethics

    Kantian Ethics

    20問 • 2年前
    Via Alarcon

    Social Contract Theory

    Social Contract Theory

    Via Alarcon · 29問 · 2年前

    Social Contract Theory

    Social Contract Theory

    29問 • 2年前
    Via Alarcon

    Moral Relativism

    Moral Relativism

    Via Alarcon · 31問 · 2年前

    Moral Relativism

    Moral Relativism

    31問 • 2年前
    Via Alarcon

    FINALS: Muscular System

    FINALS: Muscular System

    Via Alarcon · 27問 · 2年前

    FINALS: Muscular System

    FINALS: Muscular System

    27問 • 2年前
    Via Alarcon

    FINALS: Circulatory System

    FINALS: Circulatory System

    Via Alarcon · 28問 · 2年前

    FINALS: Circulatory System

    FINALS: Circulatory System

    28問 • 2年前
    Via Alarcon

    FINALS: Lymphatic System

    FINALS: Lymphatic System

    Via Alarcon · 30問 · 2年前

    FINALS: Lymphatic System

    FINALS: Lymphatic System

    30問 • 2年前
    Via Alarcon

    FINAL EXAM - Laboratory

    FINAL EXAM - Laboratory

    Via Alarcon · 82問 · 2年前

    FINAL EXAM - Laboratory

    FINAL EXAM - Laboratory

    82問 • 2年前
    Via Alarcon

    MIDTERMS (1)

    MIDTERMS (1)

    Via Alarcon · 74問 · 2年前

    MIDTERMS (1)

    MIDTERMS (1)

    74問 • 2年前
    Via Alarcon

    MIDTERMS (2)

    MIDTERMS (2)

    Via Alarcon · 39問 · 2年前

    MIDTERMS (2)

    MIDTERMS (2)

    39問 • 2年前
    Via Alarcon

    MIDTERMS

    MIDTERMS

    Via Alarcon · 100問 · 2年前

    MIDTERMS

    MIDTERMS

    100問 • 2年前
    Via Alarcon

    MIDTERMS

    MIDTERMS

    Via Alarcon · 57問 · 2年前

    MIDTERMS

    MIDTERMS

    57問 • 2年前
    Via Alarcon

    LECTURE MIDTERM EXAM

    LECTURE MIDTERM EXAM

    Via Alarcon · 57問 · 2年前

    LECTURE MIDTERM EXAM

    LECTURE MIDTERM EXAM

    57問 • 2年前
    Via Alarcon

    MIDTERMS (3)

    MIDTERMS (3)

    Via Alarcon · 16問 · 2年前

    MIDTERMS (3)

    MIDTERMS (3)

    16問 • 2年前
    Via Alarcon

    Cell-to-cell Communication

    Cell-to-cell Communication

    Via Alarcon · 24問 · 2年前

    Cell-to-cell Communication

    Cell-to-cell Communication

    24問 • 2年前
    Via Alarcon

    Axis Specification in Drosophila and Axis Formation in Amphibians

    Axis Specification in Drosophila and Axis Formation in Amphibians

    Via Alarcon · 31問 · 2年前

    Axis Specification in Drosophila and Axis Formation in Amphibians

    Axis Specification in Drosophila and Axis Formation in Amphibians

    31問 • 2年前
    Via Alarcon

    Early Development in Amphibians and Fish

    Early Development in Amphibians and Fish

    Via Alarcon · 17問 · 2年前

    Early Development in Amphibians and Fish

    Early Development in Amphibians and Fish

    17問 • 2年前
    Via Alarcon

    Early Development in Birds and Mammals

    Early Development in Birds and Mammals

    Via Alarcon · 14問 · 2年前

    Early Development in Birds and Mammals

    Early Development in Birds and Mammals

    14問 • 2年前
    Via Alarcon

    問題一覧

  • 1

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 1

    Article 1 sets the stage for the Declaration by specifying its focus on ethical considerations in the fields of medicine and life sciences applied to humans. It acknowledges that while addressed to States, the guidance is relevant to a wide range of actors involved in biomedical and health research.

  • 2

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 2

    Article 2 establishes the broad and encompassing goals of the Declaration, ranging from providing guidance to States and various entities to promoting ethical considerations, equitable access, and the conservation of biodiversity in the context of biomedical and health research.

  • 3

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 3

    Article 3 emphasizes the central importance of respecting human dignity, human rights, and fundamental freedoms, and it places a clear priority on safeguarding the interests and welfare of individuals above other considerations in the realm of biomedical and health research.

  • 4

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 4

    Article 4 emphasizes the ethical imperative to balance the pursuit of benefits with the duty to minimize harm in the context of biomedical and health research. It highlights the commitment to prioritizing the well-being and safety of individuals involved in these practices.

  • 5

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 5

    Article 5 highlights the importance of autonomy in decision-making, the responsibility that comes with it, and the need to safeguard the rights and interests of those who may not have the capacity to exercise autonomy.

  • 6

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 6

    Article 6 establishes the fundamental principles of informed consent for both medical interventions and scientific research, ensuring that individuals have the right to make decisions about their own bodies and participation in research, with a strong emphasis on providing adequate information and the ability to withdraw consent without disadvantage. It also addresses considerations when dealing with group or community-based research.

  • 7

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 7

    Article 7 emphasizes the importance of safeguarding individuals without the capacity to consent, ensuring that any research or medical interventions are carried out with their best interest in mind, involving them in decision-making processes to the greatest extent possible, and respecting their right to refuse participation in research.

  • 8

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 8

    Article 8 highlights the ethical imperative to consider and address human vulnerability in the context of scientific and medical practices. It emphasizes the need to protect those who are particularly vulnerable and underscores the importance of respecting the personal integrity of individuals undergoing medical procedures or participating in research.

  • 9

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 9

    Article 9 emphasizes the importance of respecting people's privacy and keeping their personal information confidential. It means that when researchers collect someone's personal information for a specific purpose, they should only use or share that information for that same purpose, unless there's a good reason based on international laws and human rights standards. In simple terms, it's about being careful and respectful when using and sharing people's private information in medical and health research.

  • 10

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 10

    Article 10 of the Universal Declaration on Biomedical and Health Research emphasizes the importance of treating all individuals equally, with fairness and justice, and respecting their fundamental rights and dignity. In simple terms, it means that in medical and health research, everyone should be treated fairly and with respect, regardless of their background or circumstances, ensuring that no one is discriminated against and that justice prevails. Here are simple explanations for these terms: 1. Equality: This means that everyone should have the same opportunities and rights. It's like a fair game where everyone starts with an equal chance. 2. Justice: Justice is about fairness and treating people according to what is right and morally acceptable. It's like making sure that punishments and rewards are given based on what people deserve. 3. Equity: Equity is similar to equality but recognizes that people may need different levels of support to achieve the same outcome. It's like giving everyone a boost or extra help so that they can all reach the same goal, even if they start from different places. These concepts aim to ensure that people are treated fairly and have the same basic rights and opportunities, regardless of their differences.

  • 11

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 11

    Article 11 of the Universal Declaration on Biomedical and Health Research emphasizes that no one, whether as an individual or as part of a group, should be treated unfairly or looked down upon for any reason. This includes not discriminating against people or creating negative stereotypes based on things like their race, gender, beliefs, or any other characteristic. It's all about treating everyone with respect and dignity, upholding their human rights and freedoms.

  • 12

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 12

    Article 12 of the Universal Declaration on Biomedical and Health Research highlights the significance of respecting and acknowledging the variety of cultures and different ways of life. However, it's important to note that cultural diversity and pluralism should not be used as an excuse to violate human dignity, human rights, or the principles outlined in the declaration. In other words, while celebrating cultural diversity is important, it should never be used as a reason to harm people's rights or limit the principles established in the declaration.

  • 13

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 13

    Article 13 promotes the idea that we should come together, both as individuals and nations, to support each other's health and well-being through collaboration and unity.

  • 14

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 14

    Article 14 underscores the responsibility of governments and society to ensure that everyone has the opportunity to lead a healthy life, regardless of their background, and to work towards a society where health is valued and accessible to all.

  • 15

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 15

    Article 15 stresses the importance of ensuring that the advantages arising from scientific research are accessible to all, particularly those in need, and that these benefits are shared in ethical and equitable ways, without using them to manipulate people into participating in research.

  • 16

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 16

    Article 16 underscores the ethical responsibility to carefully consider and weigh the implications of life sciences on the well-being and genetic makeup of future generations. This reflects the commitment to approaching scientific and medical advancements with a long-term perspective and ensuring that they align with ethical principles and respect for the interests of future generations.

  • 17

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 17

    Article 17 underscores the need to consider our connection to nature, respect the environment and biodiversity, honor traditional knowledge, and recognize our role in preserving the Earth for the well-being of all life forms, including humans.

  • 18

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 18

    Article 18 encourages ethical decision-making by professionals, the use of the best available scientific knowledge, regular engagement in dialogue, and the promotion of inclusive public debates on bioethical issues.

  • 19

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 19

    Article 19 underscores the need for specialized committees to oversee and guide ethical considerations in research, clinical settings, and technological developments. These committees also contribute to the broader goal of fostering public awareness and education in the field of bioethics.

  • 20

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 20

    Article 20 highlights the need to proactively assess and manage risks in the domains of medicine, life sciences, and associated technologies. This is crucial to ensuring the ethical conduct of research and practices, safeguarding the well-being of individuals, and minimizing any potential harm that may arise from these activities.

  • 21

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 21

    Article 21 outlines principles to guide ethical conduct in transnational biomedical and health research, promoting consistency with the Declaration's principles, fairness in collaboration, and protection against potential abuses such as bioterrorism and illicit trafficking.

  • 22

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 22

    Article 22 highlights the responsibility of states to actively implement the principles of the Declaration within their jurisdictions. This includes adopting appropriate measures, supporting educational initiatives, and encouraging the formation of ethical committees to ensure ethical considerations in biomedical and health research.

  • 23

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 23

    Article 23 emphasizes the need for education and awareness programs that focus on bioethics at various levels. It recognizes the importance of international collaboration and the involvement of different organizations in fostering a better understanding of the ethical aspects of scientific and technological developments in the field of biomedicine and health research.

  • 24

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 24

    Article 24 emphasizes the importance of global cooperation in scientific endeavors, with a focus on facilitating the exchange of knowledge and resources between developed and developing nations. It also highlights the ethical imperative of solidarity, especially towards vulnerable populations and those facing challenges due to health or environmental conditions.

  • 25

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 25

    Article 25 assigns UNESCO the responsibility of actively spreading awareness about the ethical principles in the Declaration and seeks collaboration with bioethics committees to strengthen the ethical framework in the field of biomedical and health research.

  • 26

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 26

    Article 26 encourages the understanding that the principles in the Declaration are not isolated but form a cohesive ethical framework. It stresses the importance of considering each principle in relation to the others, recognizing their complementary nature in addressing ethical challenges in the realm of biomedical and health research.

  • 27

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 27

    Article 27 acknowledges that there might be circumstances where the principles outlined in the Declaration need to be limited, but such limitations should be justified by law and be in alignment with international human rights standards. The specified conditions for limitation are focused on areas like public safety, criminal investigations, public health, and the protection of rights and freedoms.

  • 28

    TELL ME THE KEY POINTS IN THIS ARTICLE: Article 28

    Article 28 unequivocally states that the principles and guidelines outlined in the Declaration should not be used to justify or engage in any activities that go against fundamental human rights, freedoms, or human dignity. It reinforces the commitment to upholding ethical standards and respecting the inherent value and rights of individuals.